Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies.
通过共价和前药/双药靶向策略,合理设计的 BCR-ABL 激酶抑制剂可改善白血病治疗
期刊:Journal of Advanced Research
影响因子:13
doi:10.1016/j.jare.2024.09.008
Sun Jie, Lou Liang, Zhu Chengjun, Chen Peng, Tang Guanghui, Gu Mingxi, Xia Shu, Dong Xiao, Zhang Zhi-Min, Gao Liqian, Yao Shao Q, Xiao Qicai